Public health, war and cross-border challenges: the recent cVDPV2 polio outbreak in Gaza DOI Creative Commons
Itamar Grotto,

Hazem Agha,

Ahmad Abu Al-Halaweh

et al.

EClinicalMedicine, Journal Year: 2025, Volume and Issue: 81, P. 103136 - 103136

Published: Feb. 28, 2025

SummaryThe recent vaccine-derived poliovirus type 2 (cVDPV2) outbreak in Gaza, linked to strains circulating Egypt, highlights the challenges of maintaining vaccination efforts conflict zones. Amid prolonged hostilities and a deteriorating healthcare system, coverage has significantly declined, leaving many children vulnerable other preventable diseases. This report analysed outbreak's context, strategies, outcomes by reviewing data, environmental surveillance reports, public health interventions. It focused on novel oral polio vaccine (nOPV2) campaigns their effectiveness mitigating transmission. The outbreak, detected June 2024, included six samples one confirmed case poliomyelitis 10-month-old child. Despite operational challenges, campaign immunised 560,000 under 10 years September 2024. However, ongoing violence delayed subsequent rounds vaccination, particularly northern Gaza. Contributing factors hesitancy, logistical hurdles, safety risks workers face. Regional collaboration remains limited despite cross-border transmission risks. Gaza illustrates critical need for robust programs, enhanced surveillance, international cooperation prevent resurgence. Addressing hesitancy is vital. Sustained funding innovative including nOPV2 use, are essential combat outbreaks fragile settings advance global eradication efforts.FundingNo additional was used preparation this report.

Language: Английский

Public health, war and cross-border challenges: the recent cVDPV2 polio outbreak in Gaza DOI Creative Commons
Itamar Grotto,

Hazem Agha,

Ahmad Abu Al-Halaweh

et al.

EClinicalMedicine, Journal Year: 2025, Volume and Issue: 81, P. 103136 - 103136

Published: Feb. 28, 2025

SummaryThe recent vaccine-derived poliovirus type 2 (cVDPV2) outbreak in Gaza, linked to strains circulating Egypt, highlights the challenges of maintaining vaccination efforts conflict zones. Amid prolonged hostilities and a deteriorating healthcare system, coverage has significantly declined, leaving many children vulnerable other preventable diseases. This report analysed outbreak's context, strategies, outcomes by reviewing data, environmental surveillance reports, public health interventions. It focused on novel oral polio vaccine (nOPV2) campaigns their effectiveness mitigating transmission. The outbreak, detected June 2024, included six samples one confirmed case poliomyelitis 10-month-old child. Despite operational challenges, campaign immunised 560,000 under 10 years September 2024. However, ongoing violence delayed subsequent rounds vaccination, particularly northern Gaza. Contributing factors hesitancy, logistical hurdles, safety risks workers face. Regional collaboration remains limited despite cross-border transmission risks. Gaza illustrates critical need for robust programs, enhanced surveillance, international cooperation prevent resurgence. Addressing hesitancy is vital. Sustained funding innovative including nOPV2 use, are essential combat outbreaks fragile settings advance global eradication efforts.FundingNo additional was used preparation this report.

Language: Английский

Citations

1